Blogs and News

Discover our latest news and blog articles, dedicated to demystifying drug development, medicine, clinical research, and ethics.

3 reasons why choosing a smaller CRO can boost your clinical trial

If you’re looking for the right CRO for your clinical trial, you’re likely considering many factors, including expertise, prior success, budget… but what’s size got to do with it? More than you might think. In this blog post, we look at the benefits of partnering with a smaller CRO.

3 Ways to make decentralization support patient centricity

Used in the right way, decentralization can help put patients at the heart of a clinical trial. But if a fully decentralized or hybrid trial is designed and implemented without considering participants’ perspectives, it can result in gaps in data, low participant retention and delays.

How Regulation and Technology Impacted Clinical Research in 2023

This has been a year of change in the clinical trials landscape, with developments in regulation and the evolution of technology driving the move toward more patient centricity. Here we look at some of the highlights.

Take a peek behind the scenes: how Siron Clinical works with clients

Choosing a partner to support your clinical trial is a big decision, and understanding what your collaboration might look like can help. After more than two decades of working with a multitude of clients, Siron Clinical has perfected the process from RFP and trial...

Five tips for keeping up-to-date with the latest in clinical trials

In the fast-moving field of clinical trials, it can be challenging to keep up-to-date with the latest news, views, and changes. But with new regulation frequently appearing around the world and technological innovation changing the face of clinical research, it’s more...

Preparation, quality and the local touch: Siron Clinical’s experience with the CTIS

Now nearing the end of their second year in use, the EU’s Clinical Trial Regulation and its associated Clinical Trials Information System (CTIS) have meant some big changes for sponsors and others involved in designing, getting approval for, and running clinical...

How small biotech can overcome clinical trial hurdles

Small biotech companies are responsible for a significant proportion of newly approved medicines, especially for rare diseases. But with limited resources, budget constraints and a lean structure, they face many challenges before they can help patients. Here we look...

Quality assurance – why it’s important and how to do it

Quality assurance is a critical element of a clinical trial, as it ensures the safety of the participants, as well as the reliability and integrity of the documentation and data, and therefore the validity of your results. But what does it entail, when should it happen, and how can you get it right? We share our insights.

Recruitment, decentralization and transparency: a round-up of the latest clinical trial news

With new regulations and guidance promoting transparency, growing calls for better representation, and accelerated developments in technology, the clinical trials landscape is changing continuously. Here is a round-up of the big trends of 2023 so far. At the end of...

Four factors to consider for your cardiovascular clinical trial

Cardiovascular clinical trials are essential in developing interventions like treatments and medical devices for a wide range of cardiovascular diseases. The sheer size and complexity of cardiovascular trials is just one of the factors that make this therapeutic area...